Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 3,716	$ 3,489
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	320	(285)
Inventories and other assets	(427)	(68)
Accounts payable and accrued expenses	(676)	(459)
Depreciation and amortization	1,723	1,614
Income taxes	880	(4)
Losses (gains) on sales of facilities	2	(213)
Amortization of debt issuance costs and discounts	25	17
Share-based compensation	197	199
Other	101	150
Net cash provided by operating activities	5,861	4,440
Cash flows from investing activities:
Purchase of property and equipment	(2,167)	(2,399)
Acquisition of hospitals and health care entities	(326)	(131)
Sales of hospitals and health care entities	167	311
Change in investments	41	(14)
Other	2	(2)
Net cash used in investing activities	(2,283)	(2,235)
Cash flows from financing activities:
Issuance of long-term debt	5,233	4,483
Net change in short-term borrowings and revolving credit facilities	1,768	(1,030)
Repayment of long-term debt	(5,660)	(2,269)
Distributions to noncontrolling interests	(394)	(338)
Payment of debt issuance costs	(57)	(40)
Payment of dividends	(351)	(356)
Repurchase of common stock	(5,011)	(2,547)
Other	(112)	(212)
Net cash used in financing activities	(4,584)	(2,309)
Effect of exchange rate changes on cash and cash equivalents	12	0
Change in cash and cash equivalents	(994)	(104)
Cash and cash equivalents at beginning of period	1,933	935
Cash and cash equivalents at end of period	939	831
Interest payments	1,074	943
Income tax payments, net	$ 146	$ 999